Find a Trial Site Near You
This clinical trial for relapsed/refractory epNECs is sponsored by Boehringer Ingelheim and is currently enrolling patients. Participating sites with their contact details are mentioned in the table below.
| Hospital Name | Location | Contact Number | Email Address |
UNIV UZ Gent | Gent, Belgium, 9000 | 80049616 | |
UZ Leuven | Leuven, Belgium, 3000 | 80049616 |
| Hospital Name | Location | Contact Number | Email Address |
West China Hospital | Chengdu, China, 610041 | 4001200553 | |
Sir Run Run Shaw Hospital, Zhejiang University, School of Medicine | Hangzhou, China, 310016 | 4001200553 | |
Qilu Hospital, Shangdong University | Jinan, China, 250012 | 4001200553 | |
960 Hospital of the Chinese People's Liberation Army | Jinan, China, 250031 | 4001200553 | |
The Second Affiliated Hospital to Nanchang University | Nanchang, China, 330006 | 4001200553 |
Not yet recruiting in Part 2
| Hospital Name | Location | Contact Number | Email Address |
National Cancer Center Hospital East | Chiba, Kashiwa, Japan, 277-8577 | 120201230 | |
Kindai University Hospital | Osaka, OsakaSayama, Japan, 589-8511 | 120201230 | |
Osaka International Cancer Institute | Osaka, Osaka, Japan, 541-8567 | 120201230 | |
National Cancer Center Hospital | Tokyo, Chuo-ku, Japan, 104-0045 | 120201230 | |
Japanese Foundation for Cancer Research | Tokyo, Koto-ku, Japan, 135-8550 | 120201230 |
| Hospital Name | Location | Contact Number | Email Address |
Severance Hospital | Seoul, Korea, Republic of, 03722 | 808802084 | |
Samsung Medical Center | Seoul, Korea, Republic of, 06351 | 808802084 |
Not yet recruiting in Part 2
| Hospital Name | Location | Contact Number | Email Address |
Leicester Royal Infirmary | Leicester, United Kingdom, LE1 5WW | 8000514022 | |
Freeman Hospital | Newcastle Upon Tyne, United Kingdom, NE7 7DN | 8000514022 |
Pipeline compound(s) are under pre-clinical and/or clinical investigation and have not been approved by regulatory authorities for commercial use in patients. Efficacy and safety have not been established and there is no guarantee that they will become commercially available for the use(s) under investigation.